Skip navigation
Toggle navigation
Menu
Home
About
Browse
Help / Contact
My Spiral
Home
Browse
Communities
& Collections
Browse Items by:>
Author
Title
Sponsor/Funder
You appear to have a browser that does not support javaScript or javaScript has been disabled. Dropdown menus will not work however the links contained in the dropdowns can be accessed in the
'Browse the Spiral communities and collections' of the home page.
About
Help
Help / Contact
Sign on to:
My Spiral
Search
Search:
All of Spiral
Faculty of Medicine
Department of Surgery and Cancer
Department of Surgery and Cancer
for
Current filters:
Title
Author
Date Issued
Type
Sponsor
Course
Equals
Contains
Title
Author
Date Issued
Type
Sponsor
Course
Equals
Contains
Title
Author
Date Issued
Type
Sponsor
Course
Equals
Contains
Start a new search
Add filters:
Use filters to refine the search results.
Title
Author
Date Issued
Type
Sponsor
Course
Equals
Contains
Results 1-9 of 9
previous
1
next
Item hits:
Issue Date
Title
Author(s)
4-Apr-2016
BRCA1 positively regulates FOXO3 expression by restricting FOXO3 gene methylation and epigenetic silencing through targeting EZH2 in breast cancer
Lam, EW; Gong, C; Yao, S; Gomes, AR; , et al
1-Jun-2018
The FOXO3-FOXM1 Axis: a key cancer drug target and a modulator of cancer drug resistance
Yao, S; Fan, YN; Lam, EW; , et al
12-Sep-2017
p62/SQSTM1 interacts with vimentin to enhance breast cancer metastasis
Lam, EW; Yao, S; Dallman, M; Bugeon; Bella, L, et al
13-Jul-2016
Aurora-A Kinase: A Potent Oncogene and Target for Cancer Therapy
Yan, M; Wang, C; He, B; Yang, M; Tong, M, et al
15-Aug-2016
RNF168 cooperates with RNF8 to mediate FOXM1 ubiquitination and degradation in breast cancer epirubicin treatment
Lam, EW; Kongsema, M; Zona, S; Karunarathna, U; Yao, S, et al
29-Sep-2016
FOXO3a and the MAPK p38 are activated by cetuximab to induce cell death and inhibit cell proliferation and their expression predicts cetuximab efficacy in colorectal cancer.
Marzi, L; Combes, E; ViƩ, N; Ayrolles-Torro, A; Tosi, D, et al
12-Aug-2016
11a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes.
Lemos, LG; Nestal de Moraes, G; Delbue, D; Vasconcelos, FD; Bernardo, PS, et al
13-Mar-2018
SUMOylation modulates FOXK2-mediated paclitaxel sensitivity in breast cancer cells
Nestal de Moraes, G; Ji, Z; Lavender, F; Yao, S; Zona, S, et al
8-Mar-2017
Dataset of the human homologues and orthologues of lipid-metabolic genes identified as DAF-16 targets and their roles in lipid and energy metabolism
Fan, LY; Saavedra Garcia, P; Lam, EW;
Discover
Sponsor
5
Breast Cancer Now
4
Cancer Research UK
4
Medical Research Council (MRC)
2
Breast Cancer Campaign and Breakt...
1
Biotechnology and Biological Scie...
1
Breast Cancer Campaign
Author
5
Yao, S
2
Nestal de Moraes, G
2
Zona, S
1
Ayrolles-Torro, A
1
Bella, L
1
Bernardo, PS
1
Buarque, CD
1
Bugeon
1
Combes, E
1
Costa, PR
.
next >
Date Published
2
2018
2
2017
5
2016